Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive Tacrolimus in Pediatric Atopic Dermatitis
NCT01745159Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2012
- Primary completion
- Nov 2013
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Sep 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01745159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745159.